Eli Lilly (Netherlands)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Medicine 4.5×
• Health Professions 1.6×
• Biochemistry, Genetics and Molecular Biology 1.6×
• Neuroscience 0.4×
• Environmental Science 0.1×

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Clinical Trials, Treatment Guidelines, Genomic Profiling, ALK Inhibitors, EGFR Mutations and Radiotherapy.

By volume in 2022–2025: Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Medication Adherence and Compliance and Colorectal Cancer Treatments and Studies.

1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
2. 2 Lung Cancer Research Studies Oncology 0 works
3. 3 Medication Adherence and Compliance Family Practice 0 works
4. 4 Colorectal Cancer Treatments and Studies Oncology 0 works
5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
6. 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
7. 7 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 0 works
8. 8 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
10. 10 Cancer survivorship and care Oncology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 49% lower than in 2013–2017.

• Utrecht University
• University Medical Center Utrecht
• Rutgers Sexual and Reproductive Health and Rights
• Huisarts en Wetenschap
• Wilhelmina Children's Hospital
• University of Applied Sciences Utrecht
• Geneeskundige en Gezondheidsdienst
• Oncode Institute